Review Article
Volume 16 Issue 10 - 2020
COVID-19; A Narrative Review
Altaf Bandy1 and Farooq Ahmed Wani2*
1Department of Community Medicine, College of Medicine, Jouf University, Saudi Arabia
2Department of Pathology, College of Medicine, Jouf University, Saudi Arabia
*Corresponding Author: Farooq Ahmed Wani, Department of Pathology, College of Medicine, Jouf University, Saudi Arabia.
Received: July 04, 2020; Published: September 10, 2020




Abstract

The World Health Organization has declared the ongoing outbreak of a novel coronavirus as a global public health emergency. At present, the research work on the novel corona virus is still in its nascent stage. Depending on the current published research studies and other relevant sources, we have tried to systematically summarize the epidemiological features, clinical characteristics, diagnostic procedures, treatment protocols and preventive strategies regarding COVID-19. This review article will help the wider society to acknowledge and effectively tackle the 2019 novel coronavirus issues and will provide a reference for future research studies.

Keywords: 2019-nCoV; Coronavirus; Wuhan; Respiratory Tract Infection; SARS-CoV-2

References

  1. Patel AJD. “Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020”. Morbidity and Mortality Weekly Report 69 (2020): 140-146.
  2. Singhal T. “A Review of Coronavirus Disease-2019 (COVID-19)”. Indian Journal of Pediatrics4 (2020): 281-286.
  3. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 10223 (2020): 497-506.
  4. World Health Organization WHO Timeline - COVID-19 (2020).
  5. Chan JFW., et al. “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster”. The Lancet10223 (2020): 514-523.
  6. Goh KJ., et al. “Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection”. ANNALS Academy of Medicine Singapore 3 (2020): 108-118.
  7. Novel 2019 coronavirus genome. Virological (2020).
  8. Wang R., et al. “Emergence of SARS-like coronavirus poses new challenge in China”. Journal of Infection 3 (2020): 350-371.
  9. Song F., et al. “Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia”. Radiology 1 (2020): 210-217.
  10. Yi Y., et al. “COVID-19: what has been learned and to be learned about the novel coronavirus disease”. International Journal of Biological Sciences10 (2020): 1753-1766.
  11. Hui DSC and Zumla A. “Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features”. Infectious Disease Clinics of North America4 (2019): 869-889.
  12. Zhu N., et al. “A Novel Coronavirus from Patients with Pneumonia in China, 2019”. New England Journal of Medicine8 (2020): 727-733.
  13. Cascella M., et al. “Features, Evaluation and Treatment Coronavirus (COVID-19) (2020).
  14. Guo YR., et al. “The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status”. Military Medical Research 7 (2020).
  15. Zhou P., et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin”. Nature7798 (2020): 270-273.
  16. Angeletti S., et al. “COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis”. Journal of Medical Virology (2020).
  17. Zhang L., et al. “Origin and Evolution of the 2019 Novel Coronavirus”. Clinical Infectious Diseases (2020).
  18. Tang X., et al. “On the origin and continuing evolution of SARS-CoV-2”. National Science Review (2020).
  19. Jia HP., et al. “ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia”. Journal of Virology23 (2005): 14614-14621.
  20. Wan Y., et al. “Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus”. Journal of Virology7 (2020).
  21. De Wilde AH., et al. “Host Factors in Coronavirus Replication”. Current Topics in Microbiology and Immunology 419 (2018): 1-42.
  22. Hussain S., et al. “Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus”. Journal of Virology9 (2005): 5288-5295.
  23. L A., et al. “Recognition of Double-Stranded RNA and Activation of NF-kappaB by Toll-like Receptor 3”. Nature6857 (2001): 732-738.
  24. Takeuchi O and Akira S. “Innate Immunity to Virus Infection”. Immunological Reviews1 (2009): 75-86.
  25. Yin Y and Wunderink RG. “MERS, SARS and other coronaviruses as causes of pneumonia”. Respirology 2 (2018): 130-137.
  26. Chan-Yeung M and Xu RH. “SARS: epidemiology”. Respirology 8 (2003): S9-S14.
  27. Zaki AM., et al. “Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia”. The New England Journal of Medicine 19 (2012): 1814-1820.
  28. Cespedes MdS and Souza JCRPd. “Coronavirus: a clinical update of Covid-19”. Revista da Associação Médica Brasileira 66 (2020): 116-123.
  29. Li Q., et al. “Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia”. New England Journal of Medicine (2020).
  30. Lee PI and Hsueh PR. “Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV”. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi (2020).
  31. Kampf G., et al. “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents”. Journal of Hospital Infection3 (2020): 246-251.
  32. Centers for Disease Control and Prevention Coronavirus Disease 2019 (COVID-19) (2020).
  33. Our World in Data Case fatality rate of the ongoing COVID-19 pandemic (2020).
  34. Blumberg DA., et al. “Vertical Transmission of SARS-CoV-2: What is the Optimal Definition?” The American Journal of Perinatology 08 (2020): 769-772.
  35. Linton NMK., et al. “Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data”. Journal of Clinical Medicine 9 (2020): 538.
  36. Zhang G., et al. “Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China”. Journal of Clinical Virology 127 (2020): 104364.
  37. Lo IL., et al. “Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau”. International Journal of Biological Sciences10 (2020): 1698-1707.
  38. Centers for Disease Control and Prevention Information for Laboratories about Coronavirus (COVID-19) (2020).
  39. Zhou W and Zhong N. “The Coronavirus prevention handbook: 101 science-based tips that could save your life (2020).
  40. europa.eu. Outbreak of novel coronavirus disease 2019 (COVID-19): increased transmission globally - fifth update (2020).
  41. Wilder-Smith A and Freedman DO. “Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak”. Journal of Travel Medicine2 (2020).
  42. Tang B., et al. “Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions”. Journal of Clinical Medicine 2 (2020): 462.
  43. Chinazzi M., et al. “The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak”. Science (2020).
  44. Li JY., et al. “The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future”. Microbes and Infection2 (2020): 80-85.
  45. Graham RL., et al. “A decade after SARS: strategies for controlling emerging coronaviruses”. Nature Reviews Microbiology12 (2013): 836-848.
  46. Sanders JM., et al. “Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review”. The Journal of the American Medical Association 18 (2020): 1824-1836.
  47. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected-interim guidance (2020).
  48. Savarino A., et al. “New insights into the antiviral effects of chloroquine”. The Lancet Infectious Diseases2 (2006): 67-69.
  49. Yan Y., et al. “Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model”. Cell Research2 (2013): 300-302.
  50. Wang M., et al. “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) In vitro”. Cell Research3 (2020): 269-271.
  51. Gao J., et al. “Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies”. Bioscience Trends1 (2020): 72-73.
  52. HCQ Effective for COVID-19 in Small Randomized Trial (2020).
  53. Wake D. "World leaders urge cooperation in vaccine hunt, raise $8 billion". (2020).
  54. int. Draft landscape of COVID-19 candidate vaccines (2020).
Citation: Altaf Bandy and Farooq Ahmed Wani. “COVID-19; A Narrative Review”. EC Microbiology 16.10 (2020): 13-23.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for April Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the April issue of respective journals. Submissions are accepted on/before March 18, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk